IDEX Biometrics ASA
IDXAF
$0.20
$0.10100.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -172.94% | 68.96% | 23.54% | 24.36% | 119.35% |
| Total Depreciation and Amortization | 135.20% | -87.27% | -63.87% | -12.30% | -196.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 79.41% | -285.74% | 289.13% | -480.95% | -1,414.63% |
| Change in Net Operating Assets | -128.03% | 35,825.00% | 134.66% | 4,728.85% | 316.72% |
| Cash from Operations | -12.59% | 70.42% | 60.43% | 9.20% | 68.40% |
| Capital Expenditure | -- | -- | -- | -- | 57.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 220.00% | -108.33% | -88.52% | 102.50% | -89.13% |
| Cash from Investing | 164.00% | -100.40% | -84.78% | -92.50% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 83.76% | -88.59% | 93.85% | 71.97% | -436.70% |
| Issuance of Common Stock | 44.06% | -30.70% | -- | 42.62% | 2,826.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.84% | -63.23% | 218.49% | -62.18% | 3,093.18% |
| Foreign Exchange rate Adjustments | -345.45% | 800.00% | 166.67% | -190.00% | 191.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | 200.00% | -- | -- |
| Net Change in Cash | 106.86% | 93.39% | 88.57% | -87.89% | 86.62% |